CPT code 68540 denotes surgical excision of a lacrimal gland tumor, a procedure aimed at removing obstructing or potentially neoplastic tissue and providing a specimen for diagnostic analysis. This code captures a targeted oculoplastic surgical service that can impact patient vision, tear production, and oncologic management. Nationally, accurate coding for lacrimal gland excision matters for claims integrity, appropriate reimbursement, clinical documentation, and tracking surgical trends in ophthalmic oncology.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service (hospital operating room and ambulatory surgery centers), and the service type (surgical excision with specimen submission for pathology). The publication summarizes common billing practices and documentation elements relevant to this procedure and highlights typical modifiers used in surgical coding when applicable.

The report is intended to inform billing, coding, and clinical staff about the procedural intent and service setting associated with 68540, and to provide a foundation for reviewing benchmarks, policy updates, and payer-specific coverage considerations. Data not available in the input are noted where applicable.